Cargando…

Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients

Objective To analyze the association between the indirect methods of evaluating insulin resistance (IR) and blood pressure, anthropometric and biochemical parameters in a population of polycystic ovary syndrome (PCOS) patients. Methods Cross-sectional study performed at the Hospital Universitário de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wanderley, Miriam da Silva, Pereira, Lara Cristina Ribeiro, Santos, Carla Borges, Cunha, Vinícius Santos da, Neves, Mariam Viviane Jovino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316933/ https://www.ncbi.nlm.nih.gov/pubmed/29747212 http://dx.doi.org/10.1055/s-0038-1642634

Ejemplares similares

Polycystic Ovary Syndrome and Cardiovascular Diseases: Still an Open Door
por: Malachias, Marcus Vinicius Bolivar
Publicado: (2019)

Insulin resistance and fertility in polycystic ovary syndrome.
por: Fica, S, et al.
Publicado: (2008)

Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk
por: Pandurevic, Srdan, et al.
Publicado: (2021)

New markers of insulin resistance in polycystic ovary syndrome
por: Polak, K., et al.
Publicado: (2016)

Limitations of insulin resistance assessment in polycystic ovary syndrome
por: Lewandowski, Krzysztof C, et al.
Publicado: (2018)

Association of galactose and insulin resistance in polycystic ovary syndrome: A case-control study
por: Na, Zhijing, et al.
Publicado: (2022)

Association between polycystic ovarian morphology and insulin resistance in women with polycystic ovary syndrome
por: Lee, Jeong Eun, et al.
Publicado: (2023)

Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome
por: Hwang, Kyu Ri, et al.
Publicado: (2013)

Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease
por: Blagojevic, Iva Perovic, et al.
Publicado: (2017)

Cardiovascular disease risk in offspring of polycystic ovary syndrome
por: Shawky, Noha M.
Publicado: (2022)

Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
por: Batista, José Gomes, et al.
Publicado: (2012)

Is Insulin Resistance an Intrinsic Defect in Asian Polycystic Ovary Syndrome?
por: Lee, Hyejin, et al.
Publicado: (2013)

Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk
por: Lauretta, Rosa, et al.
Publicado: (2016)

Markers of insulin resistance in Polycystic ovary syndrome women: An update
por: Amisi, Chantal Anifa
Publicado: (2022)

Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
por: Herman, Rok, et al.
Publicado: (2023)

Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
por: Lin, Lin, et al.
Publicado: (2015)

Polycystic Ovary Syndrome in Adolescence: Challenges in Diagnosis and Management
por: Manique, Mariana Enxuto Santos, et al.
Publicado: (2022)

Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome
por: Hutchison, Samantha K., et al.
Publicado: (2008)

Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship?
por: Enzevaei, Anahita, et al.
Publicado: (2014)

Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
por: Rojas, Joselyn, et al.
Publicado: (2014)

The relation of dermcidin with insulin resistance and inflammation in women with polycystic ovary syndrome
por: Akan, Ozden Yildirim, et al.
Publicado: (2022)

Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance
por: Genazzani, Alessandro D, et al.
Publicado: (2023)

MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity
por: Cirillo, Francesca, et al.
Publicado: (2019)

Defective insulin signaling and the protective effects of dimethyldiguanide during follicular development in the ovaries of polycystic ovary syndrome
por: Wang, Fan, et al.
Publicado: (2017)

Polycystic Ovary Syndrome and Psychotic Disorder
por: Doretto, Larissa, et al.
Publicado: (2020)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Effects of Moringa oleifera on Insulin Levels and Folliculogenesis in Polycystic Ovary Syndrome Model with Insulin Resistance
por: Amelia, Dessy, et al.
Publicado: (2018)

Association between Lipid Accumulation Product and Hirsutism in Patients with Polycystic Ovary Syndrome
por: Oliveira, Flávia Ribeiro de, et al.
Publicado: (2016)

Thyroid-stimulating Hormone and Insulin Resistance: Their Association with Polycystic Ovary Syndrome without Overt Hypothyroidism
por: Benetti-Pinto, Cristina Laguna, et al.
Publicado: (2017)

Infertility management in women with polycystic ovary syndrome: a review
por: Cunha, Anita, et al.
Publicado: (2021)

Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
por: Gateva, Antoaneta, et al.
Publicado: (2012)

Cigarette Smoking and Cardiovascular Risk in Young Women with Polycystic Ovary Syndrome
por: Morotti, Elena, et al.
Publicado: (2014)

Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
por: Alalami, Huda, et al.
Publicado: (2018)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome
por: Meun, Cindy, et al.
Publicado: (2019)

Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes
por: Moulana, Mohadetheh
Publicado: (2023)

Diamel Therapy in Polycystic Ovary Syndrome Reduces Hyperinsulinaemia, Insulin Resistance, and Hyperandrogenaemia
por: Hernández-Yero, Arturo, et al.
Publicado: (2012)

Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Polycystic Ovary Syndrome
por: Xiang, Shou-Kui, et al.
Publicado: (2012)

Acute Hypertriglyceridemia Induces Platelet Hyperactivity That is Not Attenuated by Insulin in Polycystic Ovary Syndrome
por: Aye, Myint Myint, et al.
Publicado: (2014)

Recurrent Pregnancy Loss in Polycystic Ovary Syndrome: Role of Hyperhomocysteinemia and Insulin Resistance
por: Chakraborty, Pratip, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gocjolmdbjvu3v2ie4foeerhv2